A companion diagnostic is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.
This report contains market size and forecasts of Oncology Companion Diagnostic in Global, including the following market information:
Global Oncology Companion Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Oncology Companion Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oncology Companion Diagnostic include Agilent Technologies, Inc., Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., ARUP Laboratories, Abbott, Myriad Genetics, Inc. and bioMérieux SA and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Companion Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Companion Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Oncology Companion Diagnostic Market Segment Percentages, by Type, 2021 (%)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Immunohistochemistry (IHC)
In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Others
Global Oncology Companion Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Oncology Companion Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospital
Pathology/Diagnostic Laboratory
Academic Medical Center
Global Oncology Companion Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Oncology Companion Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Companion Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Oncology Companion Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies, Inc.
Illumina, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics, Inc.
bioMérieux SA
Invivoscribe, Inc.